- The key vendors in the Antidepressant Market in the US 2015-2019 are Actavis plc, Eli Lilly and Co., GlaxoSmithKline plc, Otsuka Pharmaceutical Co. Ltd. and Pfizer Inc.
London, 20 January 2015: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Antidepressant Market in the US 2015-2019. Increased awareness of depression among the medical community, patients, and the families of patients is one major trend in this market. This can result in an increase in the number of treatment-seeking patients, which in turn can result in an increase in the overall consumption of medicines. The Antidepressant market in the US is expected to decline at a CAGR of 4.08 percent during the period 2014-2019.
“The public health approach for the management of depression by government bodies such as the Centers for Disease Control and Prevention is an important trend being witnessed in the market,” says Faisal Ghaus, Vice President of TechNavio Research.
“The CDC uses the Behavioral Risk Factor Surveillance System questionnaire to track the health and risk behaviors of patients in the US annually.”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
